Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)

NCT06259175 is registered in ClinicalTrials.gov with Servier Russia as lead sponsor.

NCT NCT06259175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06259175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)
Lead sponsor
Servier Russia
Phase
Observational
Overall status
Completed
Start date
May 1, 2024
Completion date
June 1, 2025
Enrollment
396 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial hypertension, htn